Menu
GeneBe

RAP1B

RAP1B, member of RAS oncogene family, the group of RAS type GTPase family

Basic information

Region (hg38): 12:68610854-68671901

Links

ENSG00000127314NCBI:5908OMIM:179530HGNC:9857Uniprot:P61224AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • syndromic constitutional thrombocytopenia (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Thrombocytopenia 1 with multiple congenital anomalies and dysmorphic faciesADAllergy/Immunology/Infectious; CardiovascularSome individuals have been described as being susceptible to infections, and awareness may allow early and aggressive management of infections; The condition can involve congenital cardiovascular anomalies, and awareness may allow early diagnosis and management; Allergy/Immunology/Infectious; Cardiovascular; Craniofacial; Endocrine; Hematologic; Musculoskeletal; Neurologic; Renal32627184; 35451551; 37850357

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RAP1B gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RAP1B gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
1
clinvar
6
missense
1
clinvar
2
clinvar
3
nonsense
1
clinvar
1
clinvar
2
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
non coding
12
clinvar
12
Total 0 1 4 5 14

Variants in RAP1B

This is a list of pathogenic ClinVar variants found in the RAP1B region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-68648409-G-A Benign (Jun 20, 2021)1224038
12-68648715-A-G Benign (Nov 12, 2018)1254710
12-68648759-G-A Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies Pathogenic (Mar 06, 2024)2672309
12-68648759-G-T Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies Pathogenic (Mar 06, 2024)2672306
12-68648910-T-G Benign (May 14, 2021)1283372
12-68650387-A-AT RAP1B-related disorder Likely benign (Jun 06, 2019)3041426
12-68650446-C-T Uncertain significance (Mar 09, 2023)2579432
12-68650501-G-T Benign (May 22, 2021)1267109
12-68650696-T-G Benign (Jun 20, 2021)1266904
12-68652044-C-G See cases • Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies Likely pathogenic (Sep 03, 2021)1300148
12-68652046-G-A Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies Pathogenic (Mar 06, 2024)2674587
12-68652046-G-C Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies Pathogenic (Mar 06, 2024)2672307
12-68653883-G-A Benign (May 14, 2021)1246821
12-68654105-A-T Likely benign (Jul 30, 2018)754322
12-68654111-G-A Uncertain significance (Aug 08, 2017)451009
12-68654177-C-T Benign (Dec 31, 2019)709090
12-68654201-C-T Likely benign (Aug 07, 2018)745743
12-68654206-T-C Uncertain significance (Jul 26, 2022)2019742
12-68654351-T-TG Benign (May 14, 2021)1220793
12-68654358-G-A Benign (May 22, 2021)1279970
12-68654543-G-A Benign (Jun 20, 2021)1269724
12-68656332-G-A Likely benign (Jun 08, 2018)750765
12-68656386-A-G RAP1B-related disorder Likely benign (Jul 30, 2019)3034954
12-68656392-A-G Likely benign (Dec 31, 2019)733638
12-68656419-T-C Likely benign (Dec 31, 2019)722876

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RAP1Bprotein_codingprotein_codingENST00000250559 649754
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9100.0899125456011254570.00000399
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.602495.50.2510.000005031193
Missense in Polyphen329.2730.10249436
Synonymous-0.4533632.71.100.00000169336
Loss of Function2.96112.10.08235.78e-7150

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000008820.00000882
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: GTP-binding protein that possesses intrinsic GTPase activity. Contributes to the polarizing activity of KRIT1 and CDH5 in the establishment and maintenance of correct endothelial cell polarity and vascular lumen. Required for the localization of phosphorylated PRKCZ, PARD3 and TIAM1 to the cell junction. Plays a role in the establishment of basal endothelial barrier function. {ECO:0000269|PubMed:18660803, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:21840392}.;
Pathway
Platelet activation - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Renal cell carcinoma - Homo sapiens (human);Long-term potentiation - Homo sapiens (human);Neurotrophin signaling pathway - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human);Chemokine signaling pathway - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Leukocyte transendothelial migration - Homo sapiens (human);Integrin-mediated Cell Adhesion;Human Thyroid Stimulating Hormone (TSH) signaling pathway;Androgen Receptor Network in Prostate Cancer;Corticotropin-releasing hormone signaling pathway;Common Pathways Underlying Drug Addiction;Focal Adhesion;Signaling of Hepatocyte Growth Factor Receptor;MAPK Signaling Pathway;VEGFA-VEGFR2 Signaling Pathway;Chemokine signaling pathway;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;MET in type 1 papillary renal cell carcinoma;Ras Signaling;MAP2K and MAPK activation;Neutrophil degranulation;Disease;Signal Transduction;GPCR Adenosine A2A receptor;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Integrin alphaIIb beta3 signaling;HGF;Innate Immune System;Immune System;Rap1 signalling;Adaptive Immune System;MET activates RAP1 and RAC1;GPCR signaling-G alpha s Epac and ERK;Platelet Aggregation (Plug Formation);Platelet activation, signaling and aggregation;GPCR signaling-G alpha s PKA and ERK;Integrin;Integrin signaling;CXCR4-mediated signaling events;Hemostasis;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;IFN-gamma pathway;MET promotes cell motility;Signaling by MET;Signaling by Receptor Tyrosine Kinases;Signaling by RAS mutants;Signaling by high-kinase activity BRAF mutants;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Nectin adhesion pathway;Neurotrophic factor-mediated Trk receptor signaling;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Diseases of signal transduction;Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met);Signaling events mediated by focal adhesion kinase;amb2 Integrin signaling;EPHB forward signaling;PDGFR-beta signaling pathway;Trk receptor signaling mediated by the MAPK pathway;E-cadherin signaling in the nascent adherens junction (Consensus)

Intolerance Scores

loftool
0.493
rvis_EVS
-0.1
rvis_percentile_EVS
46.2

Haploinsufficiency Scores

pHI
0.668
hipred
Y
hipred_score
0.825
ghis
0.614

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.539

Gene Damage Prediction

AllRecessiveDominant
MendelianLowLowLow
Primary ImmunodeficiencyLowLowLow
CancerLowLowLow

Mouse Genome Informatics

Gene name
Rap1b
Phenotype
homeostasis/metabolism phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Zebrafish Information Network

Gene name
rap1b
Affected structure
endothelial cell
Phenotype tag
abnormal
Phenotype quality
absent

Gene ontology

Biological process
cell population proliferation;response to carbohydrate;microvillus assembly;Rap protein signal transduction;cellular response to drug;interleukin-12-mediated signaling pathway;neutrophil degranulation;establishment of endothelial barrier;positive regulation of ERK1 and ERK2 cascade;cellular response to cAMP;cellular response to gonadotropin-releasing hormone;regulation of cell junction assembly;regulation of establishment of cell polarity;negative regulation of synaptic vesicle exocytosis
Cellular component
lipid droplet;cytosol;plasma membrane;cell-cell junction;membrane;azurophil granule membrane;membrane raft;extracellular exosome
Molecular function
GTPase activity;protein binding;GTP binding;GDP binding;protein-containing complex binding